Qure AI vs Riverain Technologies
Two thoracic imaging companies with different theories about why findings get missed. Qure detects across a broad chest radiograph findings set with the widest regulatory footprint in that modality, deployed into screening programmes where radiologist capacity is thinnest, and independently evaluated in a tuberculosis context. Riverain suppresses the vessels, on the argument that nodules are missed because vasculature hides them rather than because nobody looked, which changes what the radiologist sees rather than adding a list. Those are complementary interventions and a lung programme could justify both. Neither publishes a security attestation, and both should be asked how they perform on your scanners, because thoracic algorithms are unusually sensitive to acquisition and degrade quietly when they move.
- It detects and localises across a large chest radiograph findings set with longitudinal comparison against prior scans, plus lung nodule work on computed tomography.
- Independent evaluation in a tuberculosis screening context tests the product where reading capacity is thinnest, which is a harder setting than a reading room study.
- On premise or cloud integration means images can stay inside the institution.
- Vessel suppression is a specific technical answer to a specific failure, making nodules visible that vasculature obscures rather than listing more findings.
- Long established thoracic focus means the products have been in clinical use across several generations of scanner and protocol change.
- For a lung nodule programme, a tool designed around why nodules are missed is different from a general findings detector.
Side by Side
| Axis | Q Qure AI |
R Riverain Technologies |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Do not compare these on findings counts, because suppression changes what the reader sees while detection lists what the model found, and a department may reasonably use both. Neither publishes a security attestation or trust centre, which this index records as a pattern across non United States imaging vendors rather than a fault unique to either. Ask both for performance on your own scanner mix and protocols, since thoracic algorithms are sensitive to acquisition parameters and degrade quietly when they move.